FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., indicating a supplemental approval (AP) for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Heart Failure

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

SUPPL AP for DIGOXIN (DIGOXIN)